International
More than 95% of consumers live outside the United States. Selling more U.S.-made goods and services around the world is crucial to American jobs and will help businesses small and large grow. Expanding trade also enhances the competitiveness of U.S. manufacturers while boosting the buying power of American families. The International Affairs Division of the U.S. Chamber of Commerce leads the business community’s efforts to shape global policy.
In the News
Our Work Around the World
- International
How Business Is Fortifying the U.S.-Australia AllianceA more systematic approach from government and business alike can improve economic security for both countries.
By Shannon Hayden
- International
The Lobito Corridor: Building Africa’s Most Important Railway
By Ellington Arnold
- International
Driving Digital Transformation with Côte d'Ivoire
By Dr. Guevera Yao - Climate Change
Business Delivered at COP28
By Marty Durbin
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Learn about the International Affairs Division
Around the globe, the U.S. Chamber advocates for free enterprise, competitive markets, and rules-based trade and investment as the path to economic opportunity and prosperity for all. We work every day to break down barriers to trade and investment, open new markets for American exports and investments, and make sure there's a level playing field for U.S. companies.
Chamber OnDemand
Stand Up for Free Enterprise
Join us and become a part of our movement to save the system that will secure our collective future.
Your voice is essential, and your participation is critical.
Related Litigation
Events
- EnergyChemistry Solutions SummitThursday, August 0109:00 AM EDT - 12:00 PM EDTLearn More
- InfrastructureGlobal Aerospace Summit 2024Tuesday, September 10 - Wednesday, September 1108:00 AM EDT - 05:00 PM EDTLearn More
- Employment PolicyReimagining Futures: Second Chance Employment ForumWednesday, September 1802:00 PM EDT - 07:00 PM EDTLearn More
Latest Content
This Key Vote Alert! letter was sent to the United States Senate, supporting Fiscal Year 2020 appropriations legislation.
This Hill letter was sent to the Senate Committee on Foreign Relations, on S. 482, the "Defending American Security from Kremlin Aggression Act of 2019."
This Key Vote Alert! letter was sent to the U.S. House of Representatives, supporting Fiscal Year 2020 appropriations legislation.
This Coalition letter was sent to the U.S. Congress supporting the U.S.-Mexico-Canada Agreement (USMCA).
The administration, House Democrats, and the Mexican and Canadian governments have found a path forward on this important trade agreement.
WASHINGTON, D.C. — The U.S. Chamber of Commerce welcomed news today of a Phase I trade agreement between the U.S. and China but urged the two sides to reach a comprehensive agreement in six months.
Federal Finance Minister Bill Morneau said this week that the Liberal minority government plans to implement a unilateral digital services tax (DST). This would be a mistake with broad ramifications for Canada. The digitalization of the world economy is proceeding at a remarkable clip, and it presents undeniable public-policy challenges, including in taxation. The flow of data across borders has risen 150-fold since 2005, and digital commerce has in turn become a powerful driver of growth.
Chamber sites serious disappointment by the removal of certain intellectual property provisions, including but not limited to the biologics provision. The decision to remove key intellectual property protections was based on the false assumption that these provisions would raise U.S. drug prices. In fact, the original biologics provision would have resulted in more funding for innovative medical research with no additional cost to U.S. consumers. Now, the only beneficiaries will be foreign governments and consumers who will continue to free-ride on the benefits of American research into new cures without contributing to their development.
Click here to access op-ed.